AsCas12a Gene Editing of HBG1/2Promoters with EDIT-301 Results [ASH 2023] Hematologic Malignancies 2 Mins Read53 Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic Children’s, conducted a study on…
